Mosaic ImmunoEngineering, Inc.
CPMV
$0.67
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 532.00K | 552.10K | 554.00K | 572.50K | 653.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 596.20K | 616.20K | 618.30K | 660.30K | 785.70K |
| Operating Income | -596.20K | -616.20K | -618.30K | -660.30K | -785.70K |
| Income Before Tax | -679.50K | -685.40K | -666.90K | -688.20K | -812.30K |
| Income Tax Expenses | 2.40K | 2.40K | 4.80K | 4.80K | 2.40K |
| Earnings from Continuing Operations | -0.68 | -0.69 | -0.67 | -0.69 | -0.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -681.90K | -687.80K | -671.70K | -693.00K | -814.70K |
| EBIT | -596.20K | -616.20K | -618.30K | -660.30K | -785.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.09 | -0.10 | -0.09 | -0.10 | -0.11 |
| Normalized Basic EPS | -0.06 | -0.06 | -0.06 | -0.06 | -0.07 |
| EPS Diluted | -0.10 | -0.10 | -0.10 | -0.10 | -0.12 |
| Normalized Diluted EPS | -0.06 | -0.06 | -0.06 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 28.95M | 28.95M | 28.95M | 28.95M | 28.95M |
| Average Diluted Shares Outstanding | 28.95M | 28.95M | 28.95M | 28.95M | 28.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |